Is SINTX Technologies, Inc. overvalued or undervalued?

As of 29 March 2023, SINTX Technologies, Inc. has moved from a valuation grade of "does not qualify" to "risky." The company is currently considered overvalued. Key ratios include a Price to Book Value of 1.17, an EV to Sales ratio of 0.43, and a ROCE of -822.40%. The negative P/E ratio indicates that the company is loss-making, which is further supported by its negative EV to EBIT and EV to EBITDA ratios of -0.14 and -0.16, respectively. In comparison to peers, SINTX Technologies has a worse EV to EBITDA ratio than Cardio Diagnostics Holdings, Inc. at 0.5065 and Vivos Therapeutics, Inc. at -1.0143, both of which are also classified as risky. The company's performance has significantly lagged behind the S&P 500, with a one-year return of -45.66% compared to the index's 10.26%. This combination of poor financial metrics and underperformance against peers reinforces the conclusion that SINTX Technologies, Inc. is overvalued.